Canada's Sun Life Q3 adjusted EPS beats estimates
Overview
Canada insurance and asset manager's Q3 adjusted EPS beat analyst expectations
Reported net income and EPS declined, impacted by interest rates and acquisition charges
Company raised quarterly dividend to C$1.00 per share from C$0.96
Outlook
Company did not provide specific financial guidance for the current or future periods in press release
Result Drivers
ASSET MANAGEMENT - GreenOak fee-related earnings increased 39%, driven by the Bell Partners Inc. acquisition and lower compensation expenses, partially offset by lower net seed investment income
US STOP-LOSS - US underlying net income rose on strong medical stop-loss results, reflecting double-digit premium growth and improved morbidity experience
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Adjusted EPS | Beat | C$2.05 | C$2.02 (12 Analysts) |
Q3 EPS | C$1.40 | ||
Q3 Net Income | C$785 mln | ||
Q3 Adjusted ROE | 19.00% | ||
Q3 ROE | 13.00% |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 6 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the life & health insurance peer group is "buy"
Wall Street's median 12-month price target for Sun Life Financial Inc is C$119.00, about 5.6% above its November 3 closing price of C$112.74
The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 14 three months ago
Reuters Recommended Reads
Nov 3 - Canadian insurer Intact Financial Q3 adj EPS misses estimates
Nov 3 - Canada's Fairfax Financial Q3 net earnings fall on investment losses
Nov 3 - Assurant Q3 adjusted EPS beats estimates
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)